Other studies showed that Neat1 may increase proliferation, invasion, Endothelial-to-Mesenchymal-Transition (EMT), and chemo-resistance in multiple cancer types including lung cancer, breast cancer and in renal-cell carcinoma [24-26]. This evidence concerns the gene NEAT1 and breast cancer.